Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis

Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis

Abstract Background The efficacy and safety of ambrisentan has been previously evaluated in Chinese patients with pulmonary arterial hypertension (PAH). This post-hoc analysis assessed the efficacy and safety of ambrisentan in a subgroup of connective tissue disease (CTD) patients with PAH. Methods...

Full description

Bibliographic Details
Main Authors: Mengtao Li, Zhi-Cheng Jing, Yang Li, Yong Huo, Zaixin Yu, Gangcheng Zhang, Ping Zhu, Jinming Liu, Qiushang Ji, Bingxiang Wu, Jinhua Zhong, Pingping Wang, Wenjing Zhu, Xiaofeng Zeng
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Cardiovascular Disorders
Subjects:
Ambrisentan
Chinese
Exercise capacity
Online Access:http://link.springer.com/article/10.1186/s12872-020-01591-1

Internet

http://link.springer.com/article/10.1186/s12872-020-01591-1

Similar Items